2018
DOI: 10.1080/17434440.2019.1555467
|View full text |Cite
|
Sign up to set email alerts
|

A clinical update on the mid-term clinical performance of the Ovation endograft

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…Gregory et al [11] stated that although existing published data on the ALTO device are limited, if more published data show short-to long-term results comparable to those obtained using the Ovation iX [12][13][14][15][16][17][18][19], then the ALTO device can be used more widely. However, whether ALTO devices can be successfully used in patients with more hostile aortic anatomies remains to be seen, considering the satisfac-tory results of Ovation iX use reported by Sirignano et al [17] and Morgan-Bates and Chaudhuri [19].…”
Section: Discussionmentioning
confidence: 99%
“…Gregory et al [11] stated that although existing published data on the ALTO device are limited, if more published data show short-to long-term results comparable to those obtained using the Ovation iX [12][13][14][15][16][17][18][19], then the ALTO device can be used more widely. However, whether ALTO devices can be successfully used in patients with more hostile aortic anatomies remains to be seen, considering the satisfac-tory results of Ovation iX use reported by Sirignano et al [17] and Morgan-Bates and Chaudhuri [19].…”
Section: Discussionmentioning
confidence: 99%
“…Another possibility newly described is the use of an Ovation low-profile stent graft with a polymer ring sealing technology [171] which revealed an aneurysm-related 5 year-mortality of only 99.3% and freedom of endoleak type Ia at 5 years of 95.8% in 1,296 pts analysed from the ENCORE database [172]. Half of the pts had complex anatomies.…”
Section: Novel Strategiesmentioning
confidence: 99%